中文 | English
Return
Total: 258 , 1/26
Show Home Prev Next End page: GO
Author:(Xue Ying CHENG)

1.Empirical study of input, output, outcome and impact of community-based rehabilitation stations

Xiayao CHEN ; Ying DONG ; Xue DONG ; Zhongxiang MI ; Jun CHENG ; Aimin ZHANG ; Didi LU ; Jun WANG ; Jude LIU ; Qianmo AN ; Hui GUO ; Xiaochen LIU ; Zefeng YU

Chinese Journal of Rehabilitation Theory and Practice 2026;32(1):83-89

2.Quality evaluation of Xinjiang Rehmannia glutinosa and Rehmannia glutinosa based on fingerprint and multi-component quantification combined with chemical pattern recognition.

Pan-Ying REN ; Wei ZHANG ; Xue LIU ; Juan ZHANG ; Cheng-Fu SU ; Hai-Yan GONG ; Chun-Jing YANG ; Jing-Wei LEI ; Su-Qing ZHI ; Cai-Xia XIE

China Journal of Chinese Materia Medica 2025;50(16):4630-4640

3.Causal relationship between Helicobacter pylori infection and childhood immune thrombocytopenia and influencing factors for prognosis.

Xiao-Yang ZHOU ; Mei YAN ; Ying-Bin YUE ; Hailigulli NURIDDIN ; Xue-Mei WANG ; Yong-Feng CHENG ; Chun-Can WU ; Yu LIU

Chinese Journal of Contemporary Pediatrics 2025;27(9):1105-1112

4.Early screening and diagnosis of prostate cancer based on the innovative care for chronic conditions framework.

Han-Jing ZHU ; Liang DONG ; Bin ZHAO ; Feng ZHANG ; Rong LI ; Cheng-Ye ZHU ; Jia MAO ; Zhen-Ying YANG ; Yin-Jie ZHU ; Wei XUE

National Journal of Andrology 2025;31(3):229-233

5.Impact of Laboratory Analytical Indicators on Positive Blood Culture Detection Rates: A Single Center Study.

Di WANG ; Ling Li LIU ; Rui Rui MA ; Li Jun DU ; Gui Xue CHENG ; Ya Li LIU ; Qiao Lian YI ; Ying Chun XU

Biomedical and Environmental Sciences 2025;38(3):303-312

6.First-line bevacizumab plus chemotherapy in Chinese patients with stage III/IV epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer: a phase III randomized controlled trial

Xiaohua WU ; Jihong LIU ; Ruifang AN ; Rutie YIN ; Yu ZHANG ; Huaijun ZHOU ; Aiqin HE ; Li WANG ; Jieqing ZHANG ; Ziling LIU ; Wei DUAN ; Jianqing ZHU ; Ge LOU ; Guilin CHEN ; Ying CHENG ; Fengxia XUE ; Sonja NICK ; Haiyan WANG ; Donghang LI

Journal of Gynecologic Oncology 2024;35(5):e99-

7.First-line bevacizumab plus chemotherapy in Chinese patients with stage III/IV epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer: a phase III randomized controlled trial

Xiaohua WU ; Jihong LIU ; Ruifang AN ; Rutie YIN ; Yu ZHANG ; Huaijun ZHOU ; Aiqin HE ; Li WANG ; Jieqing ZHANG ; Ziling LIU ; Wei DUAN ; Jianqing ZHU ; Ge LOU ; Guilin CHEN ; Ying CHENG ; Fengxia XUE ; Sonja NICK ; Haiyan WANG ; Donghang LI

Journal of Gynecologic Oncology 2024;35(5):e99-

8.Research progress of inducing ferroptosis of cancer stem cells against colorectal cancer

Li-Na GONG ; Meng-Ling YUAN ; Xue-Ying CHENG ; Chen-Yang XU ; Jun PAN ; Qiu-Tong CHEN ; Ling WANG ; Zi-Li ZHANG ; Mei GUO

Chinese Pharmacological Bulletin 2024;40(6):1030-1034

9.The protective effect of Jujing formula on tretina of mice with dry age-related macular degeneration

Cheng-Cheng QI ; Ruo-Ying FAN ; Xue-Sen WANG ; Shu-Lan SU ; Yue ZHU ; Sheng GUO ; Hong-Jie KANG ; Xue-Yi ZHOU ; Jin-Ao DUAN

Chinese Pharmacological Bulletin 2024;40(7):1358-1367

10.Preliminary study on gastrointestinal stress injury induced by hypobaric hypoxia in mice

Xue WEI ; Hui-Ying SHANG ; An-Ping YE ; Cheng-Rong XIAO ; Yue GAO ; Zeng-Chun MA

Chinese Pharmacological Bulletin 2024;40(8):1482-1488

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 258 , 1/26 Show Home Prev Next End page: GO